De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.

Saad A, Taylor A, Felder S, Helpman L, Bauer S, Shapira R, Levanon K, Korach J, Atamneh R, Breslauer S, Goldstein J, Peleg Hasson S.

Open source

DOI: 10.1093/oncolo/oyaf096
Published: 2025-05-01
Container: Oncologist
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyaf096,
  title = {De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.},
  author = {Saad A and  Taylor A and  Felder S and  Helpman L and  Bauer S and  Shapira R and  Levanon K and  Korach J and  Atamneh R and  Breslauer S and  Goldstein J and  Peleg Hasson S.},
  year = {2025},
  journal = {Oncologist},
  doi = {10.1093/oncolo/oyaf096},
  url = {https://doi.org/10.1093/oncolo/oyaf096}
}

RIS

TY  - JOUR
TI  - De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.
AU  - Saad A
AU  -  Taylor A
AU  -  Felder S
AU  -  Helpman L
AU  -  Bauer S
AU  -  Shapira R
AU  -  Levanon K
AU  -  Korach J
AU  -  Atamneh R
AU  -  Breslauer S
AU  -  Goldstein J
AU  -  Peleg Hasson S.
PY  - 2025
JO  - Oncologist
DO  - 10.1093/oncolo/oyaf096
UR  - https://doi.org/10.1093/oncolo/oyaf096
ER  -

APA

A, S., A, T., S, F., L, H., S, B., R, S., K, L., J, K., R, A., S, B., J, G., & S., P. H. (2025). De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.. Oncologist. https://doi.org/10.1093/oncolo/oyaf096

Source records

europe-pmc · retrieved 2026-09-25T12:57:58.463Z